Pharma major Novartis on Saturday announced that its drug Lutathera has shown significantly improved patient outcomes for gastroenteropancreatic neuroendocrine tumors....
cancers
In a recent study published in The Lancet Gastroenterology and Hepatology, researchers estimated the lifetime risk of gastrointestinal cancer and...